Functional expression of formyl peptide receptor family in human NK cells

Journal of Immunology

Volumn 183, Issue 9, 2009, Pages 5511-5517

  Kim, Sang Doo ^a   Kim, Jung Mo ^a   Jo, Seong Ho ^a   Lee, Ha Young ^a   Lee, Sun Young ^a   Shim, Jae Woong ^a   Seo, Su Kil ^b   Yun, Jeanho ^a   Bae, Yoe Sik ^a  

^a Dong A University   (South Korea)

^b Inje University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CYCLOSPORIN H; FORMYLPEPTIDE RECEPTOR; INTERLEUKIN 2; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PERTUSSIS TOXIN; STRESS ACTIVATED PROTEIN KINASE;

ARTICLE; CELL ACTIVITY; CELL FUNCTION; CELL MIGRATION; CELL STIMULATION; CHEMOTAXIS; CONTROLLED STUDY; CYTOLYSIS; ENZYME INHIBITION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION;

CHEMOTAXIS, LEUKOCYTE; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MULTIGENE FAMILY; OLIGOPEPTIDES; RECEPTORS, FORMYL PEPTIDE; RECEPTORS, LIPOXIN; SIGNAL TRANSDUCTION;

EID: 77953864826     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0802986     Document Type: Article

References (51)

1. Ortaldo, J. R., and D. L. Longo. 1988. Human natural lymphocyte effector cells: definition, analysis of activity, and clinical effectiveness. J. Natl. Cancer Inst. 80: 999-1010.
2. French, A. R., and W. M. Yokoyama. 2003. Natural killer cells and viral infections. Curr. Opin. Immunol. 15: 45-51. (Pubitemid 35454191)
3. Wu, J., and L. L. Lanier. 2003. Natural killer cells and cancer. Adv. Cancer Res. 90: 127-156.
4. Maghazachi, A. A., A. al-Aoukaty, and T. J. Schall 1994. C-C chemokines induce the chemotaxis of NK and IL-2-activated NK cells: role for G proteins. J. Immunol. 153: 4969-4977.
5. Allavena, P., G. Bianchi, D. Zhou, J. van Damme, P. Jílek, S. Sozzani, and A. Mantovani. 1994. Induction of natural killer cell migration by monocyte chemotactic protein-1, -2 and -3. Eur. J. Immunol. 24: 3233-3236.
6. Robertson, M. J. 2002. Role of chemokines in the biology of natural killer cells. J. Leukocyte Biol. 71: 173-183.
7. Maghazachi, A. A. 2005. Insights into seven and single transmembrane-spanning domain receptors and their signaling pathways in human natural killer cells. Pharmacol. Rev. 57: 339-357.
8. Le, Y., J. J. Oppenheim, and J. M. Wang. 2001. Pleiotropic roles of formyl peptide receptors. Cytokine Growth Factor Rev. 12: 91-105.
9. Le, Y., Y. Yang, Y. Cui, H. Yazawa, W. Gong, C. Qiu, and J. M. Wang. 2002. Receptors for chemotactic formyl peptides as pharmacological targets. Int. Immunopharmacol. 2: 1-13.
10. Thomas, K. M., H. Y. Pyun, and J. Navarro. 1990. Molecular cloning of the fMet-Leu-Phe receptor from neutrophils. J. Biol. Chem. 265: 20061-20064.
11. Su, S. B., J. Gao, W. Gong, N. M. Dunlop, P. M. Murphy, J. J. Oppenheim, and J. M. Wang. 1999. T21/DP107, a synthetic leucine zipper-like domain of the HIV-1 envelope gp41, attracts and activates human phagocytes by using G-protein-coupled formyl peptide receptors. J. Immunol. 162: 5924-5930.
12. Walther, A., K. Riehemann, and V. Gerke. 2000. A novel ligand of the formyl peptide receptor: annexin I regulates neutrophil extravasation by interacting with the FPR. Mol. Cell 5: 831-840.
13. Le, Y., W. Gong, B. Li, N. M. Dunlop, W. Shen, S. B. Su, R. D. Ye, and J. M. Wang. 1999. Utilization of two seven-transmembrane, G protein-coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation. J. Immunol. 163: 6777-6784.
14. Yang, D., Q. Chen, A. P. Schmidt, G. M. Anderson, J. M. Wang, J. Wooters, J. J. Oppenheim, and O. Chertov. 2000. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J. Exp. Med. 192: 1069-1074.
15. 4 receptor. J. Biol. Chem. 272: 6972-6978.
16. Su, S. B., W. Gong, J. L. Gao, W. Shen, P. M. Murphy, J. J. Oppenheim, and J. M. Wang. 1999. A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J. Exp. Med. 189: 395-402.
17. 4 receptor. Blood 95: 1810-1818.
18. Klein, C., J. I. Paul, K. Sauvé, M. M. Schmidt, L. Arcangeli, J. Ransom, J. Trueheart, J. P. Manfredi, J. R. Broach, and A. J. Murphy. 1998. Identification of surrogate agonists for the human FPRL-1 receptor by autocrine selection in yeast. Nat. Biotechnol. 16: 1334-1337.
19. Betten, A., J. Bylund, T. Christophe, F. Boulay, A. Romero, K. Hellstrand, and C. Dahlgren. 2001. A proinflammatory peptide from Helicobacter pylori activates monocytes to induce lymphocyte dysfunction and apoptosis. J. Clin. Invest. 108: 1221-1228.
20. Migeotte, I., E. Riboldi, J. D. Franssen, F. Grégoire, C. Loison, V. Wittamer, M. Detheux, P. Robberecht, S. Costagliola, G. Vassart, S. Sozzani, M. Parmentier, and D. Communi. 2005. Identification and characterization of an endogenous chemotactic ligand specific for FPRL2. J. Exp. Med. 201: 83-93.
21. 4 receptors and is an agonist for the orphan monocyte-expressed chemoattractant receptor FPRL2. J. Biol. Chem. 276: 21585-21593.
22. Yang, D., Q. Chen, B. Gertz, R. He, M. Phulsuksombati, R. D. Ye, and J. J. Oppenheim. 2002. Human dendritic cells express functional formyl peptide receptor-like-2 (FPRL2) throughout maturation. J. Leukocyte Biol. 72: 598-607.
23. Braun, M. C., J. M. Wang, E. Lahey, R. L. Rabin, and B. L. Kelsall. 2001. Activation of the formyl peptide receptor by the HIV-derived peptide T-20 suppresses interleukin-12 p70 production by human monocytes. Blood 97: 3531-3536.
24. Seo, J. K., S. Y. Choi, Y. Kim, S. H. Baek, K. T. Kim, C. B. Chae, J. D. Lambeth, P. G. Suh, and S. H. Ryu. 1997. A peptide with unique receptor specificity: stimulation of phosphoinositide hydrolysis and induction of superoxide generation in human neutrophils. J. Immunol. 158: 1895-1901.
25. Campos-Martín, Y., M. Gómez del Moral, B. Gozalbo-López, J. Suela, and E. Martínez-Naves. 2004. Expression of human CD1d molecules protects target cells from NK cell-mediated cytolysis. J. Immunol. 172: 7297-7305. (Pubitemid 38747589)
26. Jeurissen, F., A. Kavelaars, M. Korstjens, D. Broeke, R. A. Franklin, E. W. Gelfand, and C. J. Heijnen. 1994. Monocytes express a non-neurokinin substance P receptor that is functionally coupled to MAP kinase. J. Immunol. 152: 2987-2994.
27. Bae, Y. S., H. Bae, Y. Kim, T. G. Lee, P. G. Suh, and S. H. Ryu. 2001. Identification of novel chemoattractant peptides for human leukocytes. Blood 97: 2854-2862.
28. Ottonello, L., G. Tortolina, M. Amelotti, and F. Dallegri. 1999. Soluble Fas ligand is chemotactic for human neutrophilic polymorphonuclear leukocytes. J. Immunol. 162: 3601-3606. (Pubitemid 29313614)
29. Alter, G., J. M. Malenfant, and M. Altfeld. 2004. CD107a as a functional marker for the identification of natural killer cell activity. J. Immunol. Methods 294: 15-22. (Pubitemid 39626587)
30. Bae, Y. S., H. J. Yi, H. Y. Lee, E. J. Jo, J. I. Kim, T. G. Lee, R. D. Ye, J. Y. Kwak, and S. H. Ryu. 2003. Differential activation of formyl peptide receptor-like 1 by peptide ligands. J. Immunol. 171: 6807-6813.
31. Wenzel-Seifert, K., C. M. Hurt, and R. Seifert. 1998. High constitutive activity of the human formyl peptide receptor. J. Biol. Chem. 273: 24181-24189.
32. Bae, Y. S., H. Y. Lee, E. J. Jo, J. I. Kim, H. K. Kang, R. D. Ye, J. Y. Kwak, and S. H. Ryu. 2004. Identification of peptides that antagonize formyl peptide receptor-like 1-mediated signaling. J. Immunol. 173: 607-614.
33. Scharton-Kersten, T., and P. Scott. 1995. The role of the innate immune response in Th1 cell development following Leishmania major infection. J. Leukocyte Biol. 57: 515-522.
34. Sebok, K., D. Woodside, A. al-Aoukaty, A. D. Ho, S. Gluck, and A. A. Maghazachi. 1993. IL-8 induces the locomotion of human IL-2-activated natural killer cells: involvement of a guanine nucleotide binding (Go) protein. J. Immunol. 150: 1524-1534.
35. Pohajdak, B., J. Gomez, F. W. Orr, N. Khalil, M. Talgoy, and A. H. Greenberg. 1986. Chemotaxis of large granular lymphocytes. J. Immunol. 136: 278-284.
36. Ruth, J. H., C. S. Haas, C. C. Park, M. A. Amin, R. J. Martinez, G. K. Haines 3rd, S. Shahrara, P. L. Campbell, and A. E. Koch. 2006. CXCL16-mediated cell recruitment to rheumatoid arthritis synovial tissue and murine lymph nodes is dependent upon the MAPK pathway. Arthritis Rheum. 54: 765-778.
37. 4. Proc. Natl. Acad. Sci. USA 103: 6913-6918.
38. Chen, K., P. Iribarren, J. Huang, L. Zhang, W. Gong, E. H. Cho, S. Lockett, N. M. Dunlop, and J. M. Wang. 2007. Induction of the formyl peptide receptor 2 in microglia by IFN-γ and synergy with CD40 ligand. J. Immunol. 178: 1759-1766.
39. Shahabuddin, S., R. Ji, P. Wang, E. Brailoiu, N. Dun, Y. Yang, M. O. Aksoy, and S. G. Kelsen. 2006. CXCR3 chemokine receptor-induced chemotaxis in human airway epithelial cells: role of p38 MAPK and PI3K signaling pathways. Am. J. Physiol. 291: C34-C39.
40. Schoenborn, J. R., and C. B. Wilson. 2007. Regulation of interferon-γ during innate and adaptive immune responses. Adv. Immunol. 96: 41-101.
41. Schroder, K., M. J. Sweet, and D. A. Hume. 2006. Signal integration between IFNγ and TLR signalling pathways in macrophages. Immunobiology 211: 511-524.
42. Platanias, L. C. 2005. Mechanisms of type-I- and type-II-interferon- mediated signalling. Nat. Rev. Immunol. 5: 375-386.
43. Lee, C. G., S. Y. Choi, S. H. Park, K. S. Park, S. H. Ryu, and Y. C. Sung. 2005. The synthetic peptide Trp-Lys-Tyr-Met-Val-D-Met as a novel adjuvant for DNA vaccine. Vaccine 23: 4703-4710.
44. Hamerman, J. A., K. Ogasawara, and L. L. Lanier. 2005. NK cells in innate immunity. Curr. Opin. Immunol. 17: 29-35.
45. low targets prime dendritic cells to induce protective CD8 T cell responses. Immunity 19: 561-569.
46. Trinchieri, G. 1997. Cytokines acting on or secreted by macrophages during intracellular infection (IL-10, IL-12, IFN-γ). Curr. Opin. Immunol. 9: 17-23. (Pubitemid 27095894)
47. Dighe, A. S., D. Campbell, C. S. Hsieh, S. Clarke, D. R. Greaves, S. Gordon, K. M. Murphy, and R. D. Schreiber. 1995. Tissue-specific targeting of cytokine unresponsiveness in transgenic mice. Immunity 3: 657-666.
48. Kang, H. K., H. Y. Lee, M. K. Kim, K. S. Park, Y. M. Park, J. Y. Kwak, and Y. S. Bae. 2005. The synthetic peptide Trp-Lys-Tyr-Met-Val-D-Met inhibits human monocyte-derived dendritic cell maturation via formyl peptide receptor and formyl peptide receptor-like 2. J. Immunol. 175: 685-692.
49. Bae, Y. S., J. Y. Song, Y. Kim, R. He, R. D. Ye, J. Y. Kwak, P. G. Suh, and S. H. Ryu. 2003. Differential activation of formyl peptide receptor signaling by peptide ligands. Mol. Pharmacol. 64: 841-847.
50. Al-Aoukaty, A., B. Rolstad, A. Giaid, and A. A. Maghazachi. 1998. MIP-3α, MIP-3β and fractalkine induce the locomotion and the mobilization of intracellular calcium, and activate the heterotrimeric G proteins in human natural killer cells. Immunology 95: 618-624.
51. Starnes, T., K. K. Rasila, M. J. Robertson, Z. Brahmi, R. Dahl, K. Christopherson, and R. Hromas. 2006. The chemokine CXCL14 (BRAK) stimulates activated NK cell migration: implications for the downregulation of CXCL14 in malignancy. Exp. Hematol. 34: 1101-1105.